News

Optimus Holding Successfully Completes Acquisition of OM Pharma

October 01, 2020

Optimus Holding has successfully completed the acquisition of OM Pharma.

Recipharm, BIAL Extend Opicapone API Supply Agreement

October 01, 2020

Recipharm and BIAL have expanded their long-term supply agreement for the global manufacture and supply of opicapone API.

Oxgene Launches TESSA Technology for AAV Manufacture at Scale

October 01, 2020

The technology is a novel, plasmid-free manufacturing system for robust and reproducible manufacture of AAV at scale.

FDA Approves GSK’s New Drug for Rare Blood Disorders

October 01, 2020

The approval of Nucala (mepolizumab) for treating hypereosinophilic syndrome represents the first drug approved for this group of rare blood disorders in nearly 14 years.

Orgenesis to Acquire Koligo Therapeutics

October 01, 2020

The acquisition will support the accelerated commercialization of Kyslecel (autologous pancreatic islets), Koligo’s personalized cell therapy for treating pancreatitis.

Catalent Announces Integrated Service for OSD

October 01, 2020

The OneXpress solution is designed to accelerate oral dosage drug development and manufacturing.

Serum Institute of India, Gavi, and Bill & Melinda Gates Foundation Pledge Another 100 Million COVID-19 Vaccine Doses to India and LMICs

October 01, 2020

The Serum Institute of India will receive upfront capital to expand manufacturing capacity, pending vaccine approval, to ensure distribution.